These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 8033308)
21. In vivo doses of butadiene epoxides as estimated from in vitro enzyme kinetics by using cob(I)alamin and measured hemoglobin adducts: an inter-species extrapolation approach. Motwani HV; Törnqvist M Toxicol Appl Pharmacol; 2014 Dec; 281(3):276-84. PubMed ID: 25448046 [TBL] [Abstract][Full Text] [Related]
22. Genetic effects of 1,3-butadiene and associated risk for heritable damage. Pacchierotti F; Adler ID; Anderson D; Brinkworth M; Demopoulos NA; Lähdetie J; Osterman-Golkar S; Peltonen K; Russo A; Tates A; Waters R Mutat Res; 1998 Jan; 397(1):93-115. PubMed ID: 9463556 [TBL] [Abstract][Full Text] [Related]
23. DNA adducts in rats and mice following exposure to [4-14C]-1,2-epoxy-3-butene and to [2,3-14C]-1,3-butadiene. Boogaard PJ; de Kloe KP; Booth ED; Watson WP Chem Biol Interact; 2004 Jun; 148(1-2):69-92. PubMed ID: 15223358 [TBL] [Abstract][Full Text] [Related]
24. Species difference in the ovarian toxicity of 1,3-butadiene epoxides in B6C3F1 mice and Sprague-Dawley rats. Doerr JK; Hollis EA; Sipes IG Toxicology; 1996 Oct; 113(1-3):128-36. PubMed ID: 8901892 [TBL] [Abstract][Full Text] [Related]
25. Comparative metabolism of low concentrations of butadiene and its monoepoxide in human and monkey hepatic microsomes. Dahl AR; Henderson RF Inhal Toxicol; 2000 May; 12(5):439-51. PubMed ID: 10880138 [TBL] [Abstract][Full Text] [Related]
26. Species differences in the production and clearance of 1,3-butadiene metabolites: a mechanistic model indicates predominantly physiological, not biochemical, control. Kohn MC; Melnick RL Carcinogenesis; 1993 Apr; 14(4):619-28. PubMed ID: 8472325 [TBL] [Abstract][Full Text] [Related]
27. Effects of the structure of a toxicokinetic model of butadiene inhalation exposure on computed production of carcinogenic intermediates. Kohn MC; Melnick RL Toxicology; 1996 Oct; 113(1-3):31-9. PubMed ID: 8901880 [TBL] [Abstract][Full Text] [Related]
28. A physiological toxicokinetic model for 1,3-butadiene in rodents and man: blood concentrations of 1,3-butadiene, its metabolically formed epoxides, and of haemoglobin adducts--relevance of glutathione depletion. Csanády GA; Kreuzer PE; Baur C; Filser JG Toxicology; 1996 Oct; 113(1-3):300-5. PubMed ID: 8901913 [TBL] [Abstract][Full Text] [Related]
29. Metabolism of 1,3-butadiene to toxicologically relevant metabolites in single-exposed mice and rats. Filser JG; Hutzler C; Meischner V; Veereshwarayya V; Csanády GA Chem Biol Interact; 2007 Mar; 166(1-3):93-103. PubMed ID: 16616907 [TBL] [Abstract][Full Text] [Related]
30. Metabolism of 1,3-butadiene: inhalation pharmacokinetics and tissue dosimetry of butadiene epoxides in rats and mice. Himmelstein MW; Turner MJ; Asgharian B; Bond JA Toxicology; 1996 Oct; 113(1-3):306-9. PubMed ID: 8901914 [TBL] [Abstract][Full Text] [Related]
31. Stereochemical aspects of the conjugation of epoxide metabolites of butadiene with glutathione in rat liver cytosol and freshly isolated rat hepatocytes. Nieusma JL; Claffey DJ; Ruth JA; Ross D Toxicol Sci; 1998 Jun; 43(2):102-9. PubMed ID: 9710951 [TBL] [Abstract][Full Text] [Related]
32. Characterization of urinary metabolites from Sprague-Dawley rats and B6C3F1 mice exposed to [1,2,3,4-13C]butadiene. Nauhaus SK; Fennell TR; Asgharian B; Bond JA; Sumner SC Chem Res Toxicol; 1996 Jun; 9(4):764-73. PubMed ID: 8831821 [TBL] [Abstract][Full Text] [Related]
33. Metabolism of butadiene monoxide by freshly isolated hepatocytes from mice and rats: different partitioning between oxidative, hydrolytic, and conjugation pathways. Kemper RA; Krause RJ; Elfarra AA Drug Metab Dispos; 2001 Jun; 29(6):830-6. PubMed ID: 11353751 [TBL] [Abstract][Full Text] [Related]
34. Germ cell mutagenicity of three metabolites of 1,3-butadiene in the rat: induction of spermatid micronuclei by butadiene mono-, di-, and diolepoxides in vivo. Lähdetie J; Peltonen K; Sjöblom T Environ Mol Mutagen; 1997; 29(3):230-9. PubMed ID: 9142165 [TBL] [Abstract][Full Text] [Related]
35. Development of a preliminary physiologically based toxicokinetic (PBTK) model for 1,3-butadiene risk assessment. Sweeney LM; Himmelstein MW; Gargas ML Chem Biol Interact; 2001 Jun; 135-136():303-22. PubMed ID: 11397398 [TBL] [Abstract][Full Text] [Related]
36. 1,3-butadiene: cancer, mutations, and adducts. Part III: In vivo mutation of the endogenous hprt genes of mice and rats by 1,3-butadiene and its metabolites. Walker VE; Meng Q Res Rep Health Eff Inst; 2000 Mar; (92):89-139; discussion 141-9. PubMed ID: 10925840 [TBL] [Abstract][Full Text] [Related]
37. Micronuclei and gene mutations in transgenic big Blue((R)) mouse and rat fibroblasts after exposure to the epoxide metabolites of 1, 3-butadiene. Erexson GL; Tindall KR Mutat Res; 2000 Dec; 472(1-2):105-17. PubMed ID: 11113703 [TBL] [Abstract][Full Text] [Related]
38. Cellular and molecular basis for species, sex and tissue differences in 1,3-butadiene metabolism. Elfarra AA; Krause RJ; Kemper RA Chem Biol Interact; 2001 Jun; 135-136():239-48. PubMed ID: 11397394 [TBL] [Abstract][Full Text] [Related]
39. Oxidation of 1,3-butadiene to (R)- and (S)-butadiene monoxide by purified recombinant cytochrome P450 2E1 from rabbit, rat and human. Nieusma JL; Claffey DJ; Koop DR; Chen W; Peter RM; Nelson SD; Ruth JA; Ross D Toxicol Lett; 1998 Mar; 95(2):123-9. PubMed ID: 9635416 [TBL] [Abstract][Full Text] [Related]
40. Determination of mutagenicity in tissues of transgenic mice following exposure to 1,3-butadiene and N-ethyl-N-nitrosourea. Recio L; Osterman-Golkar S; Csanády GA; Turner MJ; Myhr B; Moss O; Bond JA Toxicol Appl Pharmacol; 1992 Nov; 117(1):58-64. PubMed ID: 1440614 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]